Skip to main content

Advertisement

Log in

The use of nicardipine prolonged release implants (NPRI) in microsurgical clipping after aneurysmal subarachnoid haemorrhage: comparison with endovascular treatment

  • Clinical Article
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Background

Nicardipine prolonged release implants (NPRI) have been shown to decrease the incidence of cerebral vasospasm and infarcts significantly in patients after aneurysmal subarachnoid haemorrhage (SAH) following microsurgical clipping. Yet, the comparison with results after endovascular coiling is lacking. This study was conducted to determine the differences in the incidence of cerebral vasospasm and infarctions between those two treatment modalities

Methods

The design of this investigation reflects a case-control study; 27 patients suffering from acute SAH were treated by microsurgical clipping and received an intracisternal implantation of NPRI. Twenty-seven matching consecutive patients after microsurgical treatment without implantation of NPRI or endovascular treatment, respectively, served as controls. The incidence of angiographic vasospasm and cerebral infarctions were documented.

Results

All groups were comparable concerning demographics and severity of SAH. Twenty-four of 81 patients developed angiographic vasospasm (>33% constriction). The incidence of vasospasm was 48%, 44% and 11% for patients after endovascular treatment, microsurgical clipping without NPRI and microsurgical clipping with NPRI, respectively. New cerebral infarctions occurred in 28%, 22% and 7% of the treated patients, respectively. A good clinical recovery 1 year after the initial bleeding (modified Rankin scale 0–2) was seen in 48%, 50% and 77% of the treated patients, respectively.

Conclusion

The use of NPRI during microsurgical clipping was confirmed to be safe and effective. Patients who received intracisternally implanted NPRI during clipping after aneurysmal SAH yielded significantly lower vasospasm and infarction rates, and showed a better clinical outcome when compared with clipping without NPRI and also when compared with endovascular coiling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Barth M, Capelle H, Weidauer S, Weiss C, Münch E, Thomé C, Lücke T, Schmiedek P, Kasuya H, Vajkoczy P (2007) Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 38:330–336

    Article  PubMed  CAS  Google Scholar 

  2. Barth M, Pena P, Seiz M, Thomé C, Muench E, Weidauer S, Hattingen E, Kasuya H, Schmiedek P (2011) Feasibility of intraventricular nicardipine prolonged release implants in patients following aneurysmal subarachnoid hemorrhage. Br J Neurosurg [Epub ahead of print]

  3. de Oliveira JG, Beck J, Ulrich C, Rathert J, Raabe A, Seifert V (2007) Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurg Rev 30:22–30

    Article  PubMed  Google Scholar 

  4. Dietrich HH, Dacey RG (2000) Molecular keys to the problems of cerebral vasospasm. Neurosurgery 46:517–530

    Article  PubMed  CAS  Google Scholar 

  5. Dorsch NW, King MT (1994) A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage Part I: incidence and effects. J Clin Neurosci 1:19–26

    Article  PubMed  CAS  Google Scholar 

  6. Haley EC, Kassell NF, Torner JC, Truskowski LL, Germanson TP (1994) A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study. J Neurosurg 80:788–796

    Article  PubMed  Google Scholar 

  7. Hirashima Y, Kurimoto M, Hori E, Origasa H, Endo S (2005) Lower incidence of symptomatic vasospasm after subarachnoid hemorrhage owing to ruptured vertebrobasilar aneurysms. Neurosurgery 57:1110–1116

    Article  PubMed  Google Scholar 

  8. Kasuya H, Kawashima A, Sasahara A, Onda H, Hori T (2001) Development of nicardipine prolonged-release implants for preventing vasospasm. Acta Neurochir Suppl 77:217–220

    PubMed  CAS  Google Scholar 

  9. Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T (2005) Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 56:895–902

    PubMed  Google Scholar 

  10. Kasuya H, Onda H, Takeshita M, Okada Y, Hori T (2002) Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 33:1011–1015

    Article  PubMed  CAS  Google Scholar 

  11. Kawashima A, Kasuya H, Sasahara A, Miyajima M, Izawa M, Hori T (2000) Prevention of cerebral vasospasm by nicardipine prolonged-release implants in dogs. Neurol Res 22:634–641

    PubMed  CAS  Google Scholar 

  12. Krischek B, Kasuya H, Onda H, Hori T (2007) Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid hemorrhage: effect and outcome in the first 100 patients. Neurol Med Chir (Tokyo) 47:389–394

    Article  Google Scholar 

  13. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A, the CONSCIOUS-1 investigators (2008) Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39:3015–3021

    Article  PubMed  CAS  Google Scholar 

  14. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R, the International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group (2002) International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 360:1267–1274

    Article  PubMed  Google Scholar 

  15. Seifert V, Stolke D, Zimmermann M, Feldges A (1994) Prevention of delayed ischemic deficits after aneurysmal subarachnoid hemorrhage by intrathecal bolus injection of tissue plasminogen activator (rTPA). A prospective study. Acta neurochir (Wien) 128:137–143

    Article  CAS  Google Scholar 

  16. Takanashi Y, Ishida T, Meguro T, Kirchmeier MJ, Allen TM, Zhang JH (2001) Intrathecal application with liposome-entrapped Fasudil for cerebral vasospasm following subarachnoid hemorrhage in rats. J Clin Neurosci 8:557–561

    Article  PubMed  CAS  Google Scholar 

  17. Toshima M, Kassell NF, Tanaka Y, Dougherty DA (1992) Effect of intracisternal and intravenous calcitonin gene-related peptide on experimental cerebral vasospasm in rabbits. Acta Neurochir (Wien) 119:134–138

    Article  CAS  Google Scholar 

  18. Weir B, Grace M, Hansen J, Rothberg C (1978) Time course of vasospasm in man. J Neurosurg 48:173–178

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank our colleagues in the Neurological ICU for their unstinting support.

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Vajkoczy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schneider, U.C., Dreher, S., Hoffmann, KT. et al. The use of nicardipine prolonged release implants (NPRI) in microsurgical clipping after aneurysmal subarachnoid haemorrhage: comparison with endovascular treatment. Acta Neurochir 153, 2119–2125 (2011). https://doi.org/10.1007/s00701-011-1129-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-011-1129-8

Keywords

Navigation